
Revolution Medicines Rises, HPE Soars on Strong Outlook, MGM Resorts Higher
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: Revolution Medicines (RVMD) shares rallied after the cancer drugmaker reported its experimental pancreatic cancer drug, daraxonrasib, delayed painful symptoms for months and nearly doubled survival. Hewlett Packard Enterprise (HPE) gave an outlook for annual sales that topped estimates, citing massive growth in demand for the company’s servers and networking that it expects to continue through next year. The shares soared in extended trading. The shares jumped more than 20% in late trading after…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.